Výsledky vyhledávání - "Laura Kauffman"

Real-World Reductions in Healthcare Resource Utilization over 6 Months in Patients with Substance Use Disorders Treated with a Prescription Digital Therapeutic

Autor: Neel Shah, Fulton F. Velez, Samuel Colman, Laura Kauffman, Charles Ruetsch, Kathryn Anastassopoulos, Yuri Maricich

Publikováno v: Advances in Therapy. 39:4146-4156

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fe01cc54564ce89e8bc5ebfe4f4342a8
https://doi.org/10.1007/s12325-022-02215-0

Zobrazit plný text záznamu

Reduced Healthcare Resource Utilization in Patients with Opioid Use Disorder in the 12 Months After Initiation of a Prescription Digital Therapeutic

Autor: Fulton F. Velez, Kathryn P. Anastassopoulos, Samuel Colman, Neel Shah, Laura Kauffman, Sean M. Murphy, Charles Ruetsch, Yuri A. Maricich

Publikováno v: Advances in Therapy. 39:4131-4145

reSET-O, an FDA-authorized prescription digital therapeutic (PDT) delivering cognitive behavioral therapy and contingency management to patients with opioid uRetrospective analysis of healthcare claims data compared all-cause HCRU (across hospital fa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f2760d53ca53ebf780a0859bbff8bec
https://doi.org/10.1007/s12325-022-02217-y

Zobrazit plný text záznamu

Comparison of Healthcare Resource Utilization Between Patients Who Engaged or Did Not Engage With a Prescription Digital Therapeutic for Opioid Use Disorder

Autor: Charles Ruetsch, Sam Colman, Kathryn Anastassopoulos, Laura Kauffman, Yuri A. Maricich, Fulton Velez

Publikováno v: ClinicoEconomics and Outcomes Research: CEOR

Fulton F Velez,1 Sam Colman,2 Laura Kauffman,2 Charles Ruetsch,3 Kathryn Anastassopoulos,2 Yuri A Maricich1 1Pear Therapeutics, Inc., Boston, MA, USA; 2Covance Market Access, Gaithersburg, MD, USA; 3Health Analytics, Columbia, MD, USACorrespondence:

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c39e2426000290d7c7060a95d6270ca5
https://doi.org/10.2147/ceor.s334274

Zobrazit plný text záznamu

A Large Cross-Sectional Survey Study of the Prevalence of Alopecia Areata in the United States

Autor: Joseph C. Cappelleri, Kathryn Anastassopoulos, Laura Kauffman, Michael Benigno, Elena Peeva, Jennifer Lapthorn, Arash Mostaghimi, Linda H. Chen, Peter M Wahl, Margarita Udall, Shoshana R Daniel, Pratibha Chander

Publikováno v: Clinical, Cosmetic and Investigational Dermatology. 13:259-266

Purpose Alopecia areata (AA) is an autoimmune disease characterized by the development of non-scarring alopecia. The prevalence is not well known, and estimates vary considerably with no recent estimates in the United States (US). The objective of th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a5aef8cbdfe1532c03421eeedc27d9e0
https://doi.org/10.2147/ccid.s245649

Zobrazit plný text záznamu

Real-world changes in US health system hospital-based services following treatment with a prescription digital therapeutic for opioid use disorder

Autor: Laura Kauffman, Sean M. Murphy, Fulton Velez, Sam Colman, Kathryn Anastassopoulos, Yuri A. Maricich

Publikováno v: Hospital practice (1995). 49(5)

Outcomes associated with buprenorphine therapy for the treatment of opioid use disorder (OUD) are suboptimal. reSET-O is an FDA-authorized prescription digital therapeutic (PDT) delivering neurobehavioral therapy via mobile devices to patients with O

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a82c525eb63be6072a643a55e5bbecd1
https://pubmed.ncbi.nlm.nih.gov/34275401

Zobrazit plný text záznamu

Real-world reduction in healthcare resource utilization following treatment of opioid use disorder with reSET-O, a novel prescription digital therapeutic

Autor: Kathryn Anastassopoulos, Laura Kauffman, Charles Ruetsch, Fulton Velez, Sam Colman

Publikováno v: Expert review of pharmacoeconomicsoutcomes research. 21(1)

Buprenorphine medication assisted treatment (B-MAT) adherence for opioid use disorder (OUD) is suboptimal. reSET-O, an FDA-cleared prescription digital therapeutic, delivers neurobehavioral therapy (community-reinforcement approach+fluency training+c

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f8fdca0cc34fc9e9fbc578425e97c7
https://pubmed.ncbi.nlm.nih.gov/33146558

Zobrazit plný text záznamu

Effect of renal impairment (RI) on intravenous bisphosphonates (IVBP) and multiple myeloma (MM) treatment

Autor: Sam Colman, Sarah Vidito, Ningqi Hou, Laura Kauffman, Debajyoti Bhowmik, M. Intorcia

Publikováno v: Journal of Clinical Oncology. 36:e20007-e20007

e20007Background: RI is prevalent in MM patients and associated with poor survival and increased costs. IVBPs are recommended to prevent skeletal-related event (SREs), a common and devastating comp...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ccdc8496b0d2c236c3e11ee1f50620e9
https://doi.org/10.1200/jco.2018.36.15_suppl.e20007

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání